EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,768 | -56.7% | 146,781 | 0.0% | 0.00% | – |
Q2 2023 | $103,334 | -86.2% | 146,781 | -82.5% | 0.00% | – |
Q1 2023 | $750,708 | -60.7% | 837,003 | -48.3% | 0.00% | – |
Q4 2022 | $1,910,362 | -68.4% | 1,618,950 | +101.6% | 0.00% | – |
Q3 2022 | $6,047,000 | +36.7% | 803,099 | +14.3% | 0.00% | – |
Q2 2022 | $4,425,000 | -3.8% | 702,350 | +26.7% | 0.00% | – |
Q1 2022 | $4,601,000 | +62.3% | 554,315 | +1.5% | 0.00% | – |
Q4 2021 | $2,835,000 | -23.6% | 546,155 | -1.7% | 0.00% | – |
Q3 2021 | $3,712,000 | -19.5% | 555,685 | +2.6% | 0.00% | – |
Q2 2021 | $4,614,000 | +2.1% | 541,596 | +6.1% | 0.00% | – |
Q1 2021 | $4,517,000 | -26.2% | 510,366 | +2.5% | 0.00% | – |
Q4 2020 | $6,118,000 | +62.5% | 497,774 | +7.6% | 0.00% | – |
Q3 2020 | $3,764,000 | -14.7% | 462,433 | +0.6% | 0.00% | – |
Q2 2020 | $4,415,000 | +41.3% | 459,865 | +0.1% | 0.00% | – |
Q1 2020 | $3,125,000 | -52.6% | 459,549 | +3.8% | 0.00% | – |
Q4 2019 | $6,594,000 | +49.2% | 442,550 | +2.7% | 0.00% | – |
Q3 2019 | $4,419,000 | +16.1% | 431,092 | +20.1% | 0.00% | – |
Q2 2019 | $3,805,000 | +1637.4% | 358,990 | +2186.7% | 0.00% | – |
Q1 2019 | $219,000 | -42.2% | 15,699 | -52.5% | 0.00% | – |
Q1 2017 | $379,000 | +6.5% | 33,025 | +8.3% | 0.00% | – |
Q4 2016 | $356,000 | -0.3% | 30,500 | +13.8% | 0.00% | – |
Q3 2016 | $357,000 | -16.6% | 26,791 | +24.3% | 0.00% | – |
Q2 2016 | $428,000 | – | 21,548 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
CAXTON CORP | 116,884 | $970,000 | 1.21% |